CJC-1295 (No DAC)
Longevity SupportGHRH receptor stimulation; GH pulse amplification; IGF-1 axis restoration
CJC-1295 with DAC
Longevity SupportResearch ongoing — see primary literature for current evidence.
Clinical Decision Framework
When evaluating CJC-1295 (No DAC) versus CJC-1295 with DAC for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.
When to prioritize CJC-1295 (No DAC):
Select CJC-1295 (No DAC) when the primary clinical objective aligns with its core mechanism: short-acting ghrh analog (mod grf 1-29) that stimulates pulsatile gh release mimicking natural physiological rhythms.. This is particularly relevant for protocols focused on pulsatile gh release that mimics natural gh secretion patterns..
When to prioritize CJC-1295 with DAC:
Conversely, CJC-1295 with DAC is the superior choice when targeting long-acting ghrh analog with a drug affinity complex that binds albumin, extending half-life to 6-8 days for sustained gh elevation., making it the preferred agent for sustained gh elevation with less frequent dosing..
Begin Your Age Reversal Protocol for CJC-1295 (No DAC) or CJC-1295 with DAC
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing